Currently, more than 70% of the disability associated with the psychoses is completely untreatable. Virtually all of our treatments are non-specific – only research can offer the prospect of targeted treatments that act on specific brain systems.
Australia has world-renowned research centres in the neurosciences and genetics. It also has the leading psychosis research groups and high quality neuroimaging facilities co-located with clinical services. Despite these favourable conditions for a major research effort into psychotic disorders, much greater coordination is required.
A strategic direction for a national program of clinical, neuroscience, and genetic research into the psychotic disorders is urgently needed to:
This publication is based on data collected in the framework of the 2010 Australian National Survey of High Impact Psychosis (SHIP). The report also uses data collected in the framework of the National Study of Low Prevalence (Psychotic) Disorders (LPDS) 1997-1998, an epidemiological and clinical investigation which was part of the National Survey of Mental Health and Wellbeing, Australia. Click here to read The Economic Impacts of Psychosis August 2016Breaking news >